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and led necessarily to vapour characteristics for all
humans (and e-cigarette ﬂuids used) of ‘acrid’,
‘harsh’, and non-inhalable. However, that view
seems highly tenuous, especially because of the very
high concentrations of ﬂavor chemicals we have
found in many e-cigarette ﬂuids [3]. In fact, the tobacco industry has used ﬂavorants to overcome
smoke that is ‘acrid’ and ‘harsh’ for many years [4–6].
B&F:‘It would have been reasonable for the authors to
conclude that under certain conditions, overheating
of the atomiser could result in high levels of formaldehyde that could pose a risk to users…’

FORMALDEHYDE FROM E-CIGARETTES—IT’S
NOT AS SIMPLE AS SOME SUGGEST

Response:B&F are welcome to speculate about
‘overheating’, etc. However, in our Letter [7] we have
presented only facts as we found them. We stated
clearly that we did not detect the formaldehydecontaining compound when we ran the tests at the
lower power setting, and saw it at high levels only at
the higher power setting that was available on the
commercial device that we used.

In their communication here [1], and previously in the
New England Journal of Medicine [2], Bates & Farsalinos
(referred below to as B&F) make numerous assertions
and assumptions that are not supported by facts. We
address these as follows:

B&F:‘…but to engage in the kind of health impact
modelling exercise they did and to report the results
so prominently without the required caveats, in our
view, is likely to mislead readers and judging from
many of the headlines, this is indeed what happened’.

B&F:‘The authors had rigged up a battery and atomiser
combination that when operated at a higher voltage
setting would mean the atomiser ran very hot and constituents in the liquid would create thermal decomposition products, including formaldehyde. The ﬂaw in the
experiment is that under these conditions the vapour
tastes so acrid and harsh that human users will not inhale it …’

Response:Calculations of cancer risk based on
established cancer slope factors are the internationally accepted basis for cancer risk estimates and corresponding regulatory actions. As just one example,
using the same cancer slope factor as employed in
our work, Pilidis et al. [8] computed predicted numerical cancer risk values due to formaldehyde in indoor
and outdoor air in urban Ioannina, a medium-sized
(100 000 inhabitants) city in northwestern Greece.
Further, despite what B&F imply, our Letter clearly
makes the comparison only for formaldehyde in cigarettes versus formaldehyde in e-cigarettes and, for the
latter, as used only at the higher power setting we
employed. We also emphasized these points in our
earlier reply Letter in the New England Journal of
Medicine [9].

Response:
(a) Use of the term ‘rigged up’ suggests that we established makeshift or special
conditions to make the tests, when in fact we used
a commercial e-cigarette device with available power
settings; (b) regarding the statement that ‘in our
experiments the atomiser ran very hot’, all ecigarette coils necessarily reach high temperatures
to create the aerosol(s) of propylene glycol and/or
glycerol that form the basis of most e-cigarette liquids.
That the conditions used were not relevant to real
users is ipso facto false, given that we used a commercial
device at available settings, notwithstanding the speculations of B&F regarding how the vaped aerosols we
evaluated would have tasted to anyone; and
(c)
B&F are entitled to speculate that use of the higher
power setting in our work constituted ‘overheating’,
© 2015 Society for the Study of Addiction

Regardless of how extensively they may be regulated,
and how useful they will be in reducing smoking, it is clear
that electronic nicotine delivery systems (ENDSs) are here
to stay. Less clear are the extents to which this technology
may be safer than habitual use of tobacco products, and
whether ENDSs may, by themselves, lead to dependence
on nicotine as well as, unfortunately, other ‘vapable’
addictive drugs.
Addiction, 110, 1686–1691

1688

Letters to the Editor

Declaration of Interests
None.
Keywords Cancer risk, Electronic cigarettes, e-cigarettes,
formaldehyde, health effects, risk, vaping, watts.

1,2

1

JAMES F. PANKOW , ROBERT M. STRONGIN &
1

DAVID H. PEYTON

1

Department of Chemistry
2

and Civil and Environmental Engineering , Portland State University,
Portland, OR, USA
E-mail: peytond@pdx.edu

References
1. Bates C., Farsalinos K. Research letter on e-cigarette cancer risk
was so misleading it should be retracted. Addiction 2015; 110:
1686–7.
2. Nitzkin J. L., Farsalinos K., Siegel M. More on hidden formaldehyde in e-cigarette aerosols. N Engl J Med 2015; 372:
1575.
3. Tierney P. A., Karpinski C. D., Brown J. E., Luo W., Pankow J. F.
Flavour chemicals in electronic cigarette ﬂuids. Tob Control
2015. doi: 10.1136/tobaccocontrol-2014-052175 [E-pub
ahead of print] (accessed 19 May 2015).
4. Felton R. E. What ﬂavoring can do to improve sales of tobacco
products. World Tob 1972; 38: 147–8. Available at: http://legacy.library.ucsf.edu/tid/bao74a99/pdf.
5. Lefﬁngwell J. C., Young H. J., Bernasek E. Tobacco Flavoring for
Smoking Products. Winston-Salem, NC: R. J. Reynolds Tobacco
Company; 1972.
6. von Castelmur H. Smoking material and the process of making
the same. U.S. Patent 3938531 A. Tamag Basel AG, Basel,
Switzerland; 1976.
7. Jensen R. P., Luo W., Pankow J. F., Strongin R. M., Peyton D. H.
Hidden formaldehyde in e-cigarette aerosols. N Engl J Med
2015; 372: 392–394.
8. Pilidis G. A., Karakitsios S. P., Kassomenos P. A., Kazos E. A.,
Stalikas C. D. Measurements of benzene and formaldehyde in
a medium sized urban environment. Indoor/outdoor health
risk implications on special population groups. Environ Monit
Assess 2009; 150: 285–94.
9. Pankow J. F., Strongin R. M., Peyton D. H. More on hidden
formaldehyde in e-cigarette aerosols. N Engl J Med 2015;
372: 1576–7.

‘dry puff ’ phenomenon, when the power input and
atomizer combination causes high temperatures that
create a very unpleasant taste so that users avoid this
combination [1–3]. Farsalinos et al. [4] have conﬁrmed
that aldehydes are contained in the aerosol at high levels
only under these ‘dry-puff ’ conditions. The point is that
users limit their exposure to dry puff conditions by
adjusting the power input, puff depth and frequency
and liquid ﬂow to ensure that they avoid this unpleasant
experience, whatever the combination of battery and atomizer used. An experiment that overlooks this human
control feedback cannot provide reliable data on human
exposures.
Pankow et al. argue that ﬂavours would mask the
acrid taste of the dry puff; but this is speculation,
and contradicted by the fact that the phenomenon is
reported by e-cigarette users who are using ﬂavoured
e-liquid. Moreover, ﬂavours in e-cigarettes are not
added to mask any harsh and unpleasant taste but
because ﬂavourless e-liquids are bland and boring.
The authors’ conclusions, together with a press release
from the New England Journal of Medicine, predictably
created a misleading impression of the harmfulness of
e-cigarettes.
For the future, we recommend that tests of the safety
of e-cigarettes in laboratory conditions be accompanied
by user tests to assess how likely it is that those
conditions would arise in practice, and that researchers
exercise appropriate caution when generalizing their
ﬁndings.
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E-CIGARETTES NEED TO BE TESTED FOR SAFETY
UNDER REALISTIC CONDITIONS

In our view, Pankow et al. have not addressed adequately
the key criticism of their report: that they used results
from laboratory tests of e-cigarettes under conditions that
rarely occur in practice to calculate a human cancer risk.
Pankow et al. did not counter the point that their experiment created the well-recognized, and very unpleasant,
© 2015 Society for the Study of Addiction
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